Clinical trial

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

NCT07163221

Study summary

ClinicalTrials.gov

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1 Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2 Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Sham ultrasound stimulation (control) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Conventional Synthetic DMARD Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-11-03

PhaseNA

Conditions

Rheumatoid Arthritis (RA)unresolved

Interventions

Non-invasive ultrasound stimulation of the spleen - Treatment Setting 1DEVICE

Non-invasive ultrasound stimulation of the spleen - Treatment Setting 2DEVICE

Sham ultrasound stimulation (control)DEVICE

Conventional Synthetic DMARDDRUG

Sponsors & collaborators

SecondWave Systems Inc.lead sponsor

Mapped research locations

MinneapolisMinnesota, United States1 AuroraColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07163221 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.